ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2010

Aug 10, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OXGI)
CIK: 0000949858
Period of Report: 2010-08-09

Reporting Person: Smith David V (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-08-09	Employee Stock Option (Right to Buy)	$15.11	A	5500	Acquired	2020-08-09	Common Stock (5500)	Direct

Footnotes

F1: Options vests over three years, with 1/3 vesting on each of August 9, 2011, August 9, 2012 and August 9, 2013.